Supplementary
: Analysis of SNU601 transfected with hCSF1 receptor-specific siRNA. ( A) The hCSF1 receptor expression was drastically reduced by transfection of hCSF1 receptor-specific siRNA-Type1 and -Type 2 in both of SNU601 mock and SNU601 BARF1 cells. (B) All three types of hCSF1 receptor-specific siRNA did not disturb BARF1, and it was reconfirmed by further inspection using MultAlin (http://multalin.toulouse.inra.fr/multalin/). (C) BARF1-induced NFκB upregulation was observed irrespective of hCSF1R blocking. All experiments were performed in triplicate. CSF1 receptor-specific small interfering RNA (siRNA)-Type 1, -Type 2 and -Type 3 were synthesized by Genolution Pharmaceuticals (Genolution, Seoul, Korea). A scrambled siRNA (Genolution) containing a random sequence of nucleotides with no known specificity was used as a negative control. Cells were transfected with siRNA at a final concentration of 25 nM. Each siRNA sequence was: Type 1 (sense, 5′-GCGUUGAUGUUAACUUUGAUU-3′; antisense 5′-UCAAAGUUAACAUCAACGCUU-3′), Type 2 (sense, 5′-CAACAAUCUGACUUUCAUAUU-3′; antisense 5′-UAUGAAAGUCAGAUUGUUGUU-3′), Type 3 (sense, 5′-CGAUC AAGUAGAUUUCCAAUU-3′; antisense 5′-UUGGAAAUCUACUUGAUCGUU-3′) and scrambled siRNA (sense, 5′-CCUCGUGCCG UUCCAUCAGGUAGUU-3′; antisense 5′-CUACCUGAUGGAACGGCACGAGGUU-3′). Figure S5 : Endogenous miR-146a-5p levels in various cell lines. miR-146a-5p levels were noticeably higher in EBV-infected cells than in EBV-negative cells. AGS, SNU216 and SNU601 are EBV-negative stomach cancer cells. SNU719 and YCCEL1 are EBV-infected stomach cancer cells. Raji and Jijoye are EBV-infected B cells. *Cancer stage was determined via pathological assessment of TNM (tumor invasion depth-regional lymph node metastasis-distant metastasis) according to the American Joint Committee on Cancer 7th edition.

